Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

452 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.
Desreumaux P, Foussat A, Allez M, Beaugerie L, Hébuterne X, Bouhnik Y, Nachury M, Brun V, Bastian H, Belmonte N, Ticchioni M, Duchange A, Morel-Mandrino P, Neveu V, Clerget-Chossat N, Forte M, Colombel JF. Desreumaux P, et al. Among authors: forte m. Gastroenterology. 2012 Nov;143(5):1207-1217.e2. doi: 10.1053/j.gastro.2012.07.116. Epub 2012 Aug 8. Gastroenterology. 2012. PMID: 22885333 Clinical Trial.
Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.
Foussat A, Gregoire S, Clerget-Chossat N, Terrada C, Asnagli H, Lemoine FM, Klatzmann D, LeHoang P, Forte M, Bodaghi B. Foussat A, et al. Among authors: forte m. J Ocul Pharmacol Ther. 2017 May;33(4):278-284. doi: 10.1089/jop.2016.0165. J Ocul Pharmacol Ther. 2017. PMID: 28448237 Review.
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns.
Cuende N, Boniface C, Bravery C, Forte M, Giordano R, Hildebrandt M, Izeta A, Dominici M; Legal and Regulatory Affairs Committee—Europe, International Society for Cellular Therapy. Cuende N, et al. Among authors: forte m. Cytotherapy. 2014 Dec;16(12):1597-600. doi: 10.1016/j.jcyt.2014.08.007. Epub 2014 Oct 5. Cytotherapy. 2014. PMID: 25293816 Free article. No abstract available.
Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.
Dominici M, Nichols K, Srivastava A, Weiss DJ, Eldridge P, Cuende N, Deans RJ, Rasko JE, Levine AD, Turner L, Griffin DL, O'Donnell L, Forte M, Mason C, Wagena E, Janssen W, Nordon R, Wall D, Ho HN, Ruiz MA, Wilton S, Horwitz EM, Gunter KC; 2013–2015 ISCT Presidential Task Force on Unproven Cellular Therapy. Dominici M, et al. Among authors: forte m. Cytotherapy. 2015 Dec;17(12):1663-6. doi: 10.1016/j.jcyt.2015.10.007. Cytotherapy. 2015. PMID: 26589750 No abstract available.
International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges.
Alsultan A, Farge D, Kili S, Forte M, Weiss DJ, Grignon F, Boelens JJ. Alsultan A, et al. Among authors: forte m. Cytotherapy. 2024 Oct;26(10):1132-1140. doi: 10.1016/j.jcyt.2024.05.007. Epub 2024 May 9. Cytotherapy. 2024. PMID: 38804990 Free article. Review.
Welcome to ISCT 2017 London.
Forte M, Lowdell M, Rezvani K. Forte M, et al. Cytotherapy. 2017 May;19(5S):S1-S2. doi: 10.1016/j.jcyt.2017.03.007. Cytotherapy. 2017. PMID: 28473050 No abstract available.
452 results